Bilateral adrenalectomy (BLA) is a treatment option for patients with
Cushing’s Disease (CD) if transsphenoidal pituitary surgery fails or
is not a therapeutic option. For most patients, BLA eliminates endogenous
glucocorticoid and mineralocorticoid production, but for a small number of
patients, endogenous secretion of adrenal hormones from adrenal tissue
continues or recurs, leading to signs and symptoms of hypercortisolism. If
adrenal tissue is confined to the adrenal bed, it is considered adrenal
remnant tissue, while if it is outside the adrenal bed, it is
considered adrenal rest tissue. We retrospectively evaluated morning
serum cortisol, nighttime serum cortisol, nighttime salivary cortisol, and
24-h urine free cortisol on at least three occasions in 10 patients
suspected of having endogenous cortisol production. Imaging of adrenal
remnant tissue was also reviewed. Ten of 51 patients who underwent BLA
during this time period had adrenal remnant/rest tissue marked by
detectable endogenous glucocorticoid production; 9 of the 10 patients had
signs and symptoms of hypercortisolism. Localization and treatment proved
difficult. We conclude that the incidence of adrenal remnant/rest
tissue in those undergoing BLA following unsuccessful pituitary surgery was
12% although there may have been a selection bias affecting this
prevalence. The first indication of remnant tissue occurrence is a reduction
in glucocorticoid replacement with symptoms of hypercortisolism. If this
occurs, endogenous cortisol production should be tested for by cortisol
measurements using a highly specific cortisol assay while the patient is
taking dexamethasone or no glucocorticoid replacement. Endocrinologists need
to monitor the development of both adrenal remnant tissue and
Nelson’s syndrome following BLA.